John M. Evans sold $1.7M of BEAM stock

John M. Evans, CEO of Beam Therapeutics Inc. (BEAM), sold 50,000 shares of BEAM stock worth $1.7M, per an SEC Form 4 filed Jul 1, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 29, 2026, 2 days before it was made public.

BEAM has moved -31.2% since the trade date, from $34.95 to $24.03 (Nov 12, 2026 close).